Search hospitals > Ohio > Akron
Summa Health System - Akron Campus
Claim this profileAkron, Ohio 44304
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Breast cancer
Conducts research for Head and Neck Cancers
Conducts research for Prostate Cancer
276 reported clinical trials
7 medical researchers
Summary
Summa Health System - Akron Campus is a medical facility located in Akron, Ohio. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Head and Neck Cancers, Prostate Cancer and other specialties. Summa Health System - Akron Campus is involved with conducting 276 clinical trials across 355 conditions. There are 7 research doctors associated with this hospital, such as Bradley T. Clifford, Desiree E. Doncals, Stephen Andrews, MD, and Peter Bittenbender, MD.Area of expertise
1Breast Cancer
Global LeaderHER2 negative
ER positive
Stage IV
2Lung Cancer
Global LeaderStage III
Stage IV
Stage II
Top PIs
Bradley T. CliffordSumma Health System - Akron Campus2 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
17 reported clinical trials
38 drugs studied
Desiree E. DoncalsSumma Health System - Akron Campus9 years of reported clinical research
Studies Breast Cancer
Studies Lung Cancer
7 reported clinical trials
34 drugs studied
Stephen Andrews, MDSumma Health System - Akron Campus3 years of reported clinical research
Studies Cervical Cancer
Studies Cervical Adenocarcinoma
4 reported clinical trials
14 drugs studied
Peter Bittenbender, MDSumma Health7 years of reported clinical research
Studies Heart Failure
Studies Coronary Artery Stenosis
2 reported clinical trials
2 drugs studied
Clinical Trials running at Summa Health System - Akron Campus
Breast Cancer
Lung Cancer
Breast cancer
Throat Cancer
Oropharyngeal Carcinoma
Ovarian Cancer
Laryngeal Cancer
Bladder Cancer
Colorectal Cancer
Prostate Cancer
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Hormone Therapy with or without Radiation
for Breast Cancer
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Low Dose Tamoxifen
for Breast Cancer
This phase III trial compares the effect of low dose tamoxifen to usual hormonal therapy, including aromatase inhibitors, in treating post-menopausal women with hormone positive, HER2 negative early stage breast cancer. Tamoxifen is in a class of medications known as antiestrogens. It blocks the activity of estrogen (a female hormone) in the breast. This may stop the growth of some breast tumors that need estrogen to grow. Aromatase inhibitors, such as anastrozole, letrozole, and exemestane, prevent the formation of estradiol, a female hormone, by interfering with an aromatase enzyme. Aromatase inhibitors are used as a type of hormone therapy to treat postmenopausal women with hormone-dependent breast cancer. Giving low dose tamoxifen may be more effective compared to usual hormone therapy in treating post-menopausal women with hormone-positive, HER2 negative early stage breast cancer.
Recruiting2 awards Phase 38 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Summa Health System - Akron Campus?
Summa Health System - Akron Campus is a medical facility located in Akron, Ohio. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Head and Neck Cancers, Prostate Cancer and other specialties. Summa Health System - Akron Campus is involved with conducting 276 clinical trials across 355 conditions. There are 7 research doctors associated with this hospital, such as Bradley T. Clifford, Desiree E. Doncals, Stephen Andrews, MD, and Peter Bittenbender, MD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.